Treatment for Chlamydia
For uncomplicated urogenital chlamydia, treat with either azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days—both are equally effective with 97-98% cure rates, but choose azithromycin when compliance is uncertain and doxycycline when cost matters or for rectal infections. 1
Recommended First-Line Regimens
The CDC guidelines consistently recommend two equally efficacious options 1, 2:
- Azithromycin 1 g orally in a single dose
- Doxycycline 100 mg orally twice daily for 7 days
Meta-analysis of 12 randomized trials demonstrated microbial cure rates of 97% for azithromycin and 98% for doxycycline 1. These treatments prevent transmission to partners, reduce complications like pelvic inflammatory disease in women, and prevent transmission to infants during birth in pregnant women.
How to Choose Between the Two
Choose azithromycin when:
- Compliance with a 7-day regimen is questionable
- Patient has erratic healthcare-seeking behavior
- Unpredictable follow-up is expected
- You can provide directly observed therapy 1, 2
Choose doxycycline when:
- Cost is a concern (doxycycline is significantly cheaper)
- Patient has rectal chlamydia infection (emerging evidence suggests superior efficacy) 3
- Compliance can be ensured 1
The most recent European guideline (2025) now recommends doxycycline as first-line in preference to azithromycin 4, and recent research shows doxycycline better suppresses host metabolic pathways manipulated by chlamydia, reducing reactivation risk 5.
Alternative Regimens
Use these only when first-line options cannot be used 1, 2:
- Erythromycin base 500 mg orally four times daily for 7 days
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
- Ofloxacin 300 mg orally twice daily for 7 days
- Levofloxacin 500 mg orally once daily for 7 days
Important caveat: Erythromycin is less efficacious due to gastrointestinal side effects that reduce compliance. The quinolones (ofloxacin, levofloxacin) are more expensive and offer no dosing advantage over doxycycline 1.
Critical Management Points
Medication dispensing: Dispense medications on-site and directly observe the first dose to maximize compliance 1, 2.
Sexual abstinence: Patients must abstain from sexual intercourse for 7 days after single-dose therapy OR until completion of the 7-day regimen 1, 2.
Partner treatment: Treat all sex partners to prevent reinfection. Coinfection with gonorrhea is common, so consider presumptive dual therapy 1.
Rescreening: Women should be rescreened 3-4 months after treatment due to high rates of reinfection (up to 39% in some studies), which increases risk of pelvic inflammatory disease 2.
Common Pitfalls to Avoid
Don't routinely test for cure after doxycycline or azithromycin unless symptoms persist or reinfection is suspected. Testing <3 weeks post-treatment can yield false-positives from dead organisms 2, 6.
Don't use quinolones other than ofloxacin or levofloxacin—they are either unreliable or inadequately studied for chlamydia 1.
Don't forget pregnancy considerations: Azithromycin and doxycycline are contraindicated in pregnancy; use erythromycin base 500 mg four times daily for 7 days instead 7.
Don't assume azithromycin and doxycycline are interchangeable for all sites: For rectal chlamydia, doxycycline appears more effective based on recent data showing 16.9% greater reduction in recurrent infections compared to azithromycin 3.